, /PRNewswire/ — Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on reshaping vision possibilities, today announced the appointments of Jeff Francis as Vice President of Sales and Sam Fakhoury as Vice President of Quality and Operations to Orasis’ executive leadership team. Their combined expertise and leadership will support critical functions in the organization to advance the commercial launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4%, a novel eye drop for the treatment of presbyopia in adults.
“We are delighted to welcome Jeff and Sam to our executive leadership team, both recognized leaders in the eye care sector,” said Paul Smith, President and Chief Operating Officer of Orasis Pharmaceuticals. “These appointments mark a critical milestone as we build out our organization to bring an alternative treatment option to patients seeking a break from reading glasses.”
Mr. Francis is a seasoned industry leader with extensive experience in business development and commercial execution across high-growth organizations, and will focus on the …